Cargando…

Direct impact of 2 years of COVID-19 on chronic disease patients: a population-based study in a large hard-hit Italian region

OBJECTIVES: We aimed to provide a region-wide comprehensive account of the direct effects of COVID-19 on chronic disease patients, in terms of disease incidence, severity and mortality, over a 2-year pandemic period (2020–2021). DESIGN: Population-based retrospective study. SETTING/PARTICIPANTS: Adu...

Descripción completa

Detalles Bibliográficos
Autores principales: Fortuna, Daniela, Caselli, Luana, Berti, Elena, Moro, Maria Luisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619016/
https://www.ncbi.nlm.nih.gov/pubmed/37899159
http://dx.doi.org/10.1136/bmjopen-2023-073471
_version_ 1785129897845325824
author Fortuna, Daniela
Caselli, Luana
Berti, Elena
Moro, Maria Luisa
author_facet Fortuna, Daniela
Caselli, Luana
Berti, Elena
Moro, Maria Luisa
author_sort Fortuna, Daniela
collection PubMed
description OBJECTIVES: We aimed to provide a region-wide comprehensive account of the direct effects of COVID-19 on chronic disease patients, in terms of disease incidence, severity and mortality, over a 2-year pandemic period (2020–2021). DESIGN: Population-based retrospective study. SETTING/PARTICIPANTS: Adult patients, affected by at least 1 of 32 prevalent chronic conditions, residing in the Emilia-Romagna Region in Italy, during the years 2020 (N=1 791 189, 47.7% of the overall adult regional population) and 2021 (N=1 801 071, 47.8%). RESULTS: COVID-19 incidence among chronic disease patients was 4.1% (74 067 cases) in 2020 and 7.3% (126 556 cases) in 2021, varying across pathologies, with obesity and dementia showing the highest incidence. Hospitalisation rate for pneumonia or acute respiratory distress syndrome among SARS-CoV-2-positive patients was 15.4%. COVID-19-related excess mortality, that is, deaths from COVID-19 as either main or contributing (1.5% of the total) cause of death, was observed during the three pandemic waves, with observed/expected death ratios ranging from +38% (March 2020) to +11% (December 2021). Increased risks of both COVID-19-related hospitalisation and death were associated with male gender, elderly age and many pre-existing pathologies, including cardiovascular, cerebrovascular and respiratory diseases, neurological and psychiatric disorders, and metabolic dysfunctions. The higher the number of concomitant pathologies, the greater the risk of COVID-19-related adverse outcomes: the likelihood of hospitalisation and death more than doubled for people with more than two comorbidities, compared with those with one underlying condition. CONCLUSIONS: This study presents a thorough and up-to-date quantification of the direct impact of COVID-19 on chronic disease patients. The results obtained are particularly relevant considering that people with pre-existing chronic conditions accounted for almost all cases of COVID-19-related hospitalisation (82.6%) and death (91.5%) in a vast region of Italy, among the hardest hit by the pandemic.
format Online
Article
Text
id pubmed-10619016
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-106190162023-11-02 Direct impact of 2 years of COVID-19 on chronic disease patients: a population-based study in a large hard-hit Italian region Fortuna, Daniela Caselli, Luana Berti, Elena Moro, Maria Luisa BMJ Open Public Health OBJECTIVES: We aimed to provide a region-wide comprehensive account of the direct effects of COVID-19 on chronic disease patients, in terms of disease incidence, severity and mortality, over a 2-year pandemic period (2020–2021). DESIGN: Population-based retrospective study. SETTING/PARTICIPANTS: Adult patients, affected by at least 1 of 32 prevalent chronic conditions, residing in the Emilia-Romagna Region in Italy, during the years 2020 (N=1 791 189, 47.7% of the overall adult regional population) and 2021 (N=1 801 071, 47.8%). RESULTS: COVID-19 incidence among chronic disease patients was 4.1% (74 067 cases) in 2020 and 7.3% (126 556 cases) in 2021, varying across pathologies, with obesity and dementia showing the highest incidence. Hospitalisation rate for pneumonia or acute respiratory distress syndrome among SARS-CoV-2-positive patients was 15.4%. COVID-19-related excess mortality, that is, deaths from COVID-19 as either main or contributing (1.5% of the total) cause of death, was observed during the three pandemic waves, with observed/expected death ratios ranging from +38% (March 2020) to +11% (December 2021). Increased risks of both COVID-19-related hospitalisation and death were associated with male gender, elderly age and many pre-existing pathologies, including cardiovascular, cerebrovascular and respiratory diseases, neurological and psychiatric disorders, and metabolic dysfunctions. The higher the number of concomitant pathologies, the greater the risk of COVID-19-related adverse outcomes: the likelihood of hospitalisation and death more than doubled for people with more than two comorbidities, compared with those with one underlying condition. CONCLUSIONS: This study presents a thorough and up-to-date quantification of the direct impact of COVID-19 on chronic disease patients. The results obtained are particularly relevant considering that people with pre-existing chronic conditions accounted for almost all cases of COVID-19-related hospitalisation (82.6%) and death (91.5%) in a vast region of Italy, among the hardest hit by the pandemic. BMJ Publishing Group 2023-10-29 /pmc/articles/PMC10619016/ /pubmed/37899159 http://dx.doi.org/10.1136/bmjopen-2023-073471 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Public Health
Fortuna, Daniela
Caselli, Luana
Berti, Elena
Moro, Maria Luisa
Direct impact of 2 years of COVID-19 on chronic disease patients: a population-based study in a large hard-hit Italian region
title Direct impact of 2 years of COVID-19 on chronic disease patients: a population-based study in a large hard-hit Italian region
title_full Direct impact of 2 years of COVID-19 on chronic disease patients: a population-based study in a large hard-hit Italian region
title_fullStr Direct impact of 2 years of COVID-19 on chronic disease patients: a population-based study in a large hard-hit Italian region
title_full_unstemmed Direct impact of 2 years of COVID-19 on chronic disease patients: a population-based study in a large hard-hit Italian region
title_short Direct impact of 2 years of COVID-19 on chronic disease patients: a population-based study in a large hard-hit Italian region
title_sort direct impact of 2 years of covid-19 on chronic disease patients: a population-based study in a large hard-hit italian region
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619016/
https://www.ncbi.nlm.nih.gov/pubmed/37899159
http://dx.doi.org/10.1136/bmjopen-2023-073471
work_keys_str_mv AT fortunadaniela directimpactof2yearsofcovid19onchronicdiseasepatientsapopulationbasedstudyinalargehardhititalianregion
AT caselliluana directimpactof2yearsofcovid19onchronicdiseasepatientsapopulationbasedstudyinalargehardhititalianregion
AT bertielena directimpactof2yearsofcovid19onchronicdiseasepatientsapopulationbasedstudyinalargehardhititalianregion
AT moromarialuisa directimpactof2yearsofcovid19onchronicdiseasepatientsapopulationbasedstudyinalargehardhititalianregion